Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors

B J Bongers1, M Gorostiola González1,2, X Wang1

  • 1Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.

Scientific Reports
|December 13, 2022
PubMed

Insights

This study identifies G Protein-coupled receptors (GPCRs) with mutations linked to cancer, highlighting conserved motifs and discovering novel cancer targets like P2RY10 for further research.

Area of Science:

  • Biochemistry
  • Genomics
  • Oncology

Background:

  • G Protein-coupled receptors (GPCRs) are crucial drug targets and frequently mutated in cancer.
  • Understanding GPCR mutations in cancer is vital for therapeutic development.

Purpose of the Study:

  • To identify GPCRs with cancer-associated mutations by comparing patient data with natural human genetic variation.
  • To rank GPCRs based on mutation frequency and conservation for potential cancer relevance.

Main Methods:

  • Utilized mutation data from the Genomic Data Commons and natural variation data from the 1000 Genomes Project.
  • Analyzed mutation patterns across GPCR classes and conserved motifs using Two-Entropy Analysis.
  • Employed Pareto Front Ranking to prioritize GPCRs based on cancer mutation frequency and conservation.

Main Results:

  • Observed mutation enrichment in cancer patients within conserved GPCR motifs, like the Class A "DRY" motif.
  • Confirmed correlation between residue conservation and cancer mutation frequency.
  • Identified known cancer targets (LPA, mGlu receptors) and novel candidates (e.g., P2RY10).

Conclusions:

  • Presents a ranked list of GPCRs with significant cancer-associated mutations.
  • Highlights specific GPCR motifs and residues critical in cancer development.
  • Provides a foundation for experimental validation of novel GPCR cancer targets.

Related Concept Videos

G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.6K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
2.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K